3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
8
Neoplasms
3
Esophageal Neoplasms
2
Stomach Neoplasms
1
Platelet Glycoprotein IV Deficiency
1
Pancreatic Intraductal Neoplasms
1
Pancreatic Ductal Adenocarcinoma (PDAC)
1
Pancreatic Cyst
1
Neoplasm Metastasis
1
Leiomyoma
1
Jaundice, Obstructive
1
Gastrointestinal Stromal Tumors
1
Fatty Liver
1
Disease
1
Cysts
1
Colonic Neoplasms
1
Carcinoma, Pancreatic Ductal
1
Adrenal Gland Neoplasms
1
Adrenal Gland Diseases
1
Adenocarcinoma
1
Interventions
Oxaliplatin
32
Fluorouracil
24
Gemcitabine
23
Leucovorin
19
Docetaxel
19
pembrolizumab
17
Capecitabine
15
Radiotherapy
14
Irinotecan
13
Cisplatin
11
Bevacizumab
11
Nivolumab
8
130-nm albumin-bound paclitaxel
8
Trastuzumab
7
Erlotinib Hydrochloride
7
Cyclophosphamide
7
Albumin-Bound Paclitaxel
7
Radiosurgery
6
Paclitaxel
6
Taxes
5
S 1 (combination)
5
Metformin
5
Carboplatin
5
Blood Specimen Collection
5
Sunitinib
4
Sorafenib
4
Pemetrexed
4
Esophagectomy
4
Chemoradiotherapy
4
Cetuximab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Adenocarcinoma
×
Endosonography
×
Clear all
NCT06867172
2025-03-10
SPACE
Carol Davila University of Medicine and Pharmacy
Recruiting
66 enrolled